We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Neurosurgical Navigation Robot Combines AI and Machine Vision to Streamline Procedures

By HospiMedica International staff writers
Posted on 09 Aug 2022
Print article
Image: The NaoTrac CE-certified neurosurgical navigation robot has received TFDA approval (Photo courtesy of Brain Navi Biotechnology)
Image: The NaoTrac CE-certified neurosurgical navigation robot has received TFDA approval (Photo courtesy of Brain Navi Biotechnology)

Amidst the increasing demand for minimally invasive surgery, neuro-navigation has become standard in neurosurgery worldwide. Currently, most navigation systems use a “vision-based optical tracking system” during the registration step. Image-guided surgery is used for intra-operative navigation assistance for neurosurgical problems. However, such solutions require some specific space to be maintained between the device cameras, the probe, and the microscope in order to eliminate obstruction. Now, a new autopilot neurosurgical navigation robot that combines robotic technology, artificial intelligence (AI) and machine vision could assist in surgical procedures such as biopsy, deep brain stimulation (DBS), stereoelectroencephalography (SEEG), endoscopic surgery, and external ventricular drainage (EVD).

NaoTrac, a CE-certified neurosurgical navigation robot from Brain Navi Biotechnology (Hsinchu, Taiwan), uses the company’s proprietary Surface Mapping Auto-Registration Technology (SMART) technology that merges machine vision, robotics, and AI to streamline surgical procedures with real-time imaging and minimally invasive outcomes. NaoTrac can be used for surgeries like endoscopic brain surgery, cell implantation, and other operations. NaoTrac’s unique autonomous procedure enables surgical navigation with non-contact registration, pre-operative planning preparation, and choosing the surgery pathway with 3D vision for precise anatomical location.

NaoTrac has achieved approval from Taiwan's Food and Drug Administration (TFDA) and the company is now planning a submission to the FDA (U.S. Food and Drug Administration) for clearance by the end of 2022. Human trials of NaoTrac performed with EVD placement have shown that the results were good to perfect with high precision.

"The results of this report show that the average time spent on the patient registration was 1423.8 seconds. The mean target deviation was 1.68mm, and the mean angular deviation was 1.99 degrees, all within the accepted tolerance for minimal tissue damage," said Dr. Tsung-Lang, Chiu. "NaoTrac has several advantages besides the high precision, like a non-invasive, non-contact patient registration process with a fast and accurate procedure, the system provides precise navigation to the surgical target. It's also user-friendly, and has many other benefits."

Related Links:
Brain Navi Biotechnology 

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Examination Table
Powerline Backrest Top

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.